Supplementary Table 2.
Feature predisposing to bias | Inclusion of patients with postoperatively detectable PSA | Low rates of salvage treatment in control arms | Very late use of salvage radiation (PSA >1.0 ng/ml) |
---|---|---|---|
SWOG-8794 | Yes | Yes | Yes |
EORTC-22911 | Yes | Yes | Yes |
ARO-96-02 | No | Unknown | Unknown |
FinnProstate | Yes | No | No |
PSA: prostate-specific antigen.